@article{3177900,
    title = "Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with
Ring Sideroblasts and Thrombocytosis-A Case Report",
    author = "Bouchla, Anthi and Papageorgiou, Sotirios G. and Tsakiraki, Zoi and and Glezou, Eirini and Pavlidis, George and Stavroulaki, Georgia and Bazani, and Efthimia and Foukas, Periklis and Pappa, Vasiliki",
    journal = "Case Reports in Hematology",
    year = "2018",
    volume = "2018",
    publisher = "HINDAWI LTD",
    issn = "2090-6560, 2090-6579",
    doi = "10.1155/2018/2525070",
    abstract = "Plasmablastic lymphoma (PBL) is a rare, aggressive type of B-cell
non-Hodgkin lymphoma with the vast majority of patients responding
poorly to treatment or progressing shortly thereafter.
Cyclophosphamide-doxorubicin-vincristine-prednisolone (CHOP) or
CHOP-like regimens have disappointing results in this setting. We report
a case of PBL arising in a previously diagnosed
myelodysplastic/myeloproliferative (MDS/MPN) with ring sideroblasts and
thrombocytopenia (RS-T), HIV-negative patient treated with the
combination of CHOP and bortezomib. The patient achieved complete
metabolic response, which has lasted one year, longer by far than would
have been expected with the sole use of CHOP."
}